ATE264309T1 - Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren - Google Patents
Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumorenInfo
- Publication number
- ATE264309T1 ATE264309T1 AT99957309T AT99957309T ATE264309T1 AT E264309 T1 ATE264309 T1 AT E264309T1 AT 99957309 T AT99957309 T AT 99957309T AT 99957309 T AT99957309 T AT 99957309T AT E264309 T1 ATE264309 T1 AT E264309T1
- Authority
- AT
- Austria
- Prior art keywords
- tumors
- treatment
- pharmaceutical preparations
- preparations containing
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D223/08—Oxygen atoms
- C07D223/10—Oxygen atoms attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19335498A | 1998-11-17 | 1998-11-17 | |
| PCT/EP1999/008767 WO2000029382A1 (en) | 1998-11-17 | 1999-11-15 | Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE264309T1 true ATE264309T1 (de) | 2004-04-15 |
Family
ID=22713307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99957309T ATE264309T1 (de) | 1998-11-17 | 1999-11-15 | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1131297B1 (de) |
| JP (1) | JP3550545B2 (de) |
| KR (1) | KR20010080461A (de) |
| CN (1) | CN1187333C (de) |
| AR (1) | AR023914A1 (de) |
| AT (1) | ATE264309T1 (de) |
| AU (1) | AU748016B2 (de) |
| BR (1) | BR9915436A (de) |
| CA (1) | CA2347773C (de) |
| CO (1) | CO5140099A1 (de) |
| CZ (1) | CZ20011707A3 (de) |
| DE (1) | DE69916488T2 (de) |
| ES (1) | ES2221463T3 (de) |
| HU (1) | HUP0104224A3 (de) |
| ID (1) | ID28343A (de) |
| IL (1) | IL142701A0 (de) |
| NO (1) | NO20012428L (de) |
| PE (1) | PE20001241A1 (de) |
| PL (1) | PL347633A1 (de) |
| PT (1) | PT1131297E (de) |
| SK (1) | SK6692001A3 (de) |
| TR (1) | TR200101366T2 (de) |
| UY (2) | UY25807A1 (de) |
| WO (1) | WO2000029382A1 (de) |
| ZA (1) | ZA200103419B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE383341T1 (de) * | 2000-05-11 | 2008-01-15 | Novartis Pharma Gmbh | Substituierte caprolactam carbonate und ether sowie deren verwendung als anti-tumor wirkstoffe |
| US6545148B2 (en) | 2001-03-12 | 2003-04-08 | Novartis Ag | Process for preparing certain substituted caprolactams |
| JP2006528611A (ja) * | 2003-07-25 | 2006-12-21 | ノバルティス アクチエンゲゼルシャフト | 置換ラクタムおよびそれらの抗がん剤としての使用 |
| US7153846B2 (en) | 2003-10-24 | 2006-12-26 | Sanofi-Aventis Deutschland Gmbh | Bengamide derivatives, process for preparing them, and their use |
| DE10349669B3 (de) * | 2003-10-24 | 2005-05-25 | Aventis Pharma Deutschland Gmbh | Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
| FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
| FR2878528B1 (fr) * | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
| FR2901556A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation |
| FR2901554B1 (fr) | 2006-05-24 | 2011-04-01 | Sanofi Aventis | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation |
| FR2901555A1 (fr) | 2006-05-24 | 2007-11-30 | Sanofi Aventis Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
| US20130085161A1 (en) | 2010-06-17 | 2013-04-04 | Novartis Ag | Piperidinyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
| WO2011157787A1 (en) | 2010-06-17 | 2011-12-22 | Novartis Ag | Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9411841D0 (en) * | 1994-06-14 | 1994-08-03 | Pharma Mar Sa | New antitumoral compounds from jaspis sponge |
-
1999
- 1999-11-04 CO CO99069674A patent/CO5140099A1/es unknown
- 1999-11-15 PT PT99957309T patent/PT1131297E/pt unknown
- 1999-11-15 CA CA002347773A patent/CA2347773C/en not_active Expired - Fee Related
- 1999-11-15 PL PL99347633A patent/PL347633A1/xx unknown
- 1999-11-15 HU HU0104224A patent/HUP0104224A3/hu unknown
- 1999-11-15 SK SK669-2001A patent/SK6692001A3/sk unknown
- 1999-11-15 PE PE1999001155A patent/PE20001241A1/es not_active Application Discontinuation
- 1999-11-15 ES ES99957309T patent/ES2221463T3/es not_active Expired - Lifetime
- 1999-11-15 WO PCT/EP1999/008767 patent/WO2000029382A1/en active IP Right Grant
- 1999-11-15 KR KR1020017006152A patent/KR20010080461A/ko not_active Application Discontinuation
- 1999-11-15 EP EP99957309A patent/EP1131297B1/de not_active Expired - Lifetime
- 1999-11-15 IL IL14270199A patent/IL142701A0/xx unknown
- 1999-11-15 BR BR9915436-6A patent/BR9915436A/pt not_active Application Discontinuation
- 1999-11-15 AT AT99957309T patent/ATE264309T1/de not_active IP Right Cessation
- 1999-11-15 ID IDW00200100966A patent/ID28343A/id unknown
- 1999-11-15 CZ CZ20011707A patent/CZ20011707A3/cs unknown
- 1999-11-15 TR TR2001/01366T patent/TR200101366T2/xx unknown
- 1999-11-15 AR ARP990105796A patent/AR023914A1/es unknown
- 1999-11-15 AU AU15060/00A patent/AU748016B2/en not_active Ceased
- 1999-11-15 DE DE69916488T patent/DE69916488T2/de not_active Expired - Lifetime
- 1999-11-15 JP JP2000582369A patent/JP3550545B2/ja not_active Expired - Fee Related
- 1999-11-15 CN CNB998134104A patent/CN1187333C/zh not_active Expired - Fee Related
- 1999-11-17 UY UY25807A patent/UY25807A1/es unknown
-
2000
- 2000-02-25 UY UY26036A patent/UY26036A1/es unknown
-
2001
- 2001-04-26 ZA ZA200103419A patent/ZA200103419B/en unknown
- 2001-05-16 NO NO20012428A patent/NO20012428L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1326445A (zh) | 2001-12-12 |
| DE69916488D1 (de) | 2004-05-19 |
| NO20012428D0 (no) | 2001-05-16 |
| ZA200103419B (en) | 2002-06-26 |
| AR023914A1 (es) | 2002-09-04 |
| AU1506000A (en) | 2000-06-05 |
| AU748016B2 (en) | 2002-05-30 |
| ES2221463T3 (es) | 2004-12-16 |
| TR200101366T2 (tr) | 2001-10-22 |
| PL347633A1 (en) | 2002-04-22 |
| CA2347773A1 (en) | 2000-05-25 |
| PT1131297E (pt) | 2004-08-31 |
| EP1131297B1 (de) | 2004-04-14 |
| IL142701A0 (en) | 2002-03-10 |
| HUP0104224A3 (en) | 2002-04-29 |
| KR20010080461A (ko) | 2001-08-22 |
| JP2002529536A (ja) | 2002-09-10 |
| DE69916488T2 (de) | 2005-03-24 |
| UY25807A1 (es) | 2001-08-27 |
| ID28343A (id) | 2001-05-17 |
| NO20012428L (no) | 2001-07-17 |
| WO2000029382A1 (en) | 2000-05-25 |
| UY26036A1 (es) | 2001-06-29 |
| SK6692001A3 (en) | 2001-10-08 |
| PE20001241A1 (es) | 2000-11-24 |
| CA2347773C (en) | 2009-03-10 |
| EP1131297A1 (de) | 2001-09-12 |
| CZ20011707A3 (cs) | 2001-08-15 |
| HUP0104224A2 (hu) | 2002-03-28 |
| JP3550545B2 (ja) | 2004-08-04 |
| CN1187333C (zh) | 2005-02-02 |
| CO5140099A1 (es) | 2002-03-22 |
| BR9915436A (pt) | 2001-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE447947T1 (de) | Pharmazeutische zubereitungen zur behandlung von insulinresitenz | |
| DE69710095D1 (de) | Pharmazeutische zubereitung zur behandlung von diabetes | |
| ATE256463T1 (de) | Pharmazeutische zubereitung zur verwendung in der behandlung von diabetes | |
| ATE204754T1 (de) | Pharmazeutische zusammensetzung von metformin und fibrat, und ihre verwendung zur behandlung von hyperglykämie | |
| ATE235481T1 (de) | Substituierte benzopyranderivate zur behandlung von entzündungen | |
| DE60019556D1 (de) | 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE527022T1 (de) | Verwendung von cyclooxygenase-2-inhibitoren zur behandlung und vorbeugung von tumoren, von tumor- abhängigen erkrankungen und kachexie | |
| DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
| ATE318138T1 (de) | Pharmazeutisches mittel zur behandlung von diabetes | |
| DE60019555D1 (de) | 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit | |
| ATE350030T1 (de) | Nordihydroguaiaretinsäurederivate zur behandlung von tumoren | |
| DE69804659D1 (de) | 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss | |
| ATE295174T1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
| DE69833297D1 (de) | Substituierte Pyridylmethylpiperazin- und piperidinderivate, deren Herstellung und deren Verwendung in der Behandlung von Erkrankungen des Zentralnervensystems (ZNS) | |
| ATE264309T1 (de) | Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren | |
| EE03771B1 (et) | Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine | |
| DE69914951D1 (de) | Substituierte tricyclische Verbindungen und deren Verwendung zur Behandlung von sPLA2-bedingten Erkrankungen | |
| DE69420229T2 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| ATE418552T1 (de) | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz | |
| DE69925578D1 (de) | Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten | |
| DE69738320D1 (de) | Verwendung von pyrolidin-derivaten zur herstellung von arzneimitteln zur behandlung von drogenmissbrauch | |
| DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| ATE204167T1 (de) | Antikonvulsive derivate zur behandlung von psoriasis | |
| ATE288279T1 (de) | Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor | |
| ATE261965T1 (de) | Bispidin-derivate zur behandlung von herzarrhythmien |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1131297 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |